Merck Financial Statements From 2010 to 2024

MERK Stock  IDR 3,410  40.00  1.16%   
Merck Tbk financial statements provide useful quarterly and yearly information to potential Merck Tbk investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merck Tbk financial statements helps investors assess Merck Tbk's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck Tbk's valuation are summarized below:
Merck Tbk does not presently have any fundamental ratios for analysis.
Check Merck Tbk financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck Tbk's main balance sheet or income statement drivers, such as , as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck Tbk Valuation or Volatility modules.
  
This module can also supplement various Merck Tbk Technical models . Check out the analysis of Merck Tbk Correlation against competitors.

Merck Tbk Company Return On Asset Analysis

Merck Tbk's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Merck Tbk Return On Asset

    
  0.16  
Most of Merck Tbk's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Merck Tbk has a Return On Asset of 0.1573. This is 101.8% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all Indonesia stocks is notably lower than that of the firm.

Merck Tbk Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merck Tbk's current stock value. Our valuation model uses many indicators to compare Merck Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck Tbk competition to find correlations between indicators driving Merck Tbk's intrinsic value. More Info.
Merck Tbk is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.67  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck Tbk is roughly  1.48 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck Tbk's earnings, one of the primary drivers of an investment's value.

About Merck Tbk Financial Statements

Merck Tbk investors utilize fundamental indicators, such as revenue or net income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. Merck Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 405 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Merck Stock

Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.